NCT06903377 2026-01-05
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Recruiting
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Shanghai Hengrui Pharmaceutical Co., Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
Evopoint Biosciences Inc.
Spectrum Pharmaceuticals, Inc